Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct SARS-CoV-2 Antibody Responses Elicited by Natural Infection and mRNA Vaccination
Rafael Ramiro de Assis, Aarti Jain, Rie Nakajima, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22

Showing 22 citing articles:

Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients
Victoria Hall, Victor H. Ferreira, Matthew Ierullo, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 12, pp. 3980-3989
Open Access | Times Cited: 143
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
Annalisa Ciabattini, G Pastore, Fabio Fiorino, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 97
Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose
Franklin Claro, Douglas Silva, M. Sarahí Martínez Rodríguez, et al.
International Journal of Infectious Diseases (2021) Vol. 111, pp. 261-266
Open Access | Times Cited: 41
Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
Jéromine Klingler, Gregory S. Lambert, Vincenza Itri, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 35
Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim Report
Olivera Lijeskić, Ivana Klun, Marija Stamenov Djaković, et al.
Vaccines (2021) Vol. 9, Iss. 9, pp. 1031-1031
Open Access | Times Cited: 16
Evidence of SARS-Cov-2-specific memory B cells six months after vaccination with BNT162b2 mRNA vaccine
Annalisa Ciabattini, G Pastore, Fabio Fiorino, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 12
Immunogenic amino acid motifs and linear epitopes of COVID-19 mRNA vaccines
Adam V. Wisnewski, Carrie A. Redlich, Jian Liu, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0252849-e0252849
Open Access | Times Cited: 12
COVID‐19 vaccines: what do we know so far?
Paraminder Dhillon, Daniel M. Altmann, Victoria Male
FEBS Journal (2021) Vol. 288, Iss. 17, pp. 4996-5009
Open Access | Times Cited: 11
Detection of Antibody Responses against SARS-CoV-2 in Plasma and Saliva from Vaccinated and Infected Individuals
Jéromine Klingler, Gregory S. Lambert, Vincenza Itri, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol
Marie Pouquet, Dorine Decarreaux, Pol Prévot-Monsacre, et al.
Pathogens (2021) Vol. 10, Iss. 7, pp. 911-911
Open Access | Times Cited: 8
Comparison of the Development of SARS-Coronavirus-2-Specific Cellular Immunity, and Central Memory CD4+ T-Cell Responses Following Infection versus Vaccination
Kevin M. Dennehy, Eva Löll, Christine Dhillon, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1439-1439
Open Access | Times Cited: 8
Immunogenic Amino Acid Motifs and Linear Epitopes of COVID-19 mRNA Vaccines
Adam V. Wisnewski, Carrie A. Redlich, Kathy Kamath, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammation
Koen K. A. Van Rompay, Katherine J. Olstad, Rebecca L. Sammak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Risk Factors for SARS-CoV-2 Among a Cohort of Healthcare Workers in Lebanon
Carine J. Sakr, Farouk F. Abou Hassan, Lina Fakih, et al.
Workplace Health & Safety (2023) Vol. 72, Iss. 2, pp. 48-59
Closed Access | Times Cited: 1
'One Year Later' - SARS-CoV-2-Specific Immunity in Mild Cases of COVID-19
Pablo Garcia Valtanen, Christopher M. Hope, Makutiro G. Masavuli, et al.
SSRN Electronic Journal (2021)
Closed Access | Times Cited: 3
PERFORMANCE AND UTILITY OF AN ORAL FLUID-BASED RAPID POINT-OF-CARE TEST FOR SARS-COV-2 ANTIBODY RESPONSE FOLLOWING COVID-19 INFECTION OR VACCINATION
Paturi Vishnupriya Rao, Dhanalakshmi Nair-Shaef, Siting Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
SARS-CoV-2 Antibody Response to the BNT162b2 mRNA Vaccine in Persons with Past Natural Infection
Yu Min Kang, Kang Won Choe, Ki-Deok Lee, et al.
Journal of Korean Medical Science (2021) Vol. 36, Iss. 35
Open Access | Times Cited: 2
ANTIBODY RESPONSE AFTER SARS-CoV-2 mRNA VACCINE IN NAÏVE AND PREVIOUSLY INFECTED HEALTHCARE WORKERS
Adina Huţanu, Minodora Dobreanu
Health Problems of Civilization (2021) Vol. 16, Iss. 1, pp. 48-56
Open Access | Times Cited: 1
Covid-19 Vaccine-Induced (IgG4) Autoimmune Disease: Case Study with Therapeutic and Dietary Regimen
Greg Maguire
Authorea (Authorea) (2023)
Open Access
Covid-19 Vaccine-Induced Autoimmune Disease: Case Study with Therapeutic and Dietary Regimen
Greg Maguire, Greg Maguire
Authorea (Authorea) (2022)
Open Access
Covid-19 Vaccine-Induced Autoimmune Disease: Case Study with Therapeutic and Dietary Regimen
Greg Maguire
Authorea (Authorea) (2022)
Open Access
Humoral immune responses against seasonal coronaviruses predict efficiency of SARS-CoV-2 spike targeting, FcγR activation, and corresponding COVID-19 disease severity
José Luis Velasco Garrido, Matías A. Medina, Felipe Bravo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access
Page 1

Scroll to top